Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Aug 31:8:92.
doi: 10.1186/1477-7525-8-92.

Upper-body morbidity following breast cancer treatment is common, may persist longer-term and adversely influences quality of life

Sandra C Hayes  1 , Sheree Rye, Diana Battistutta, Tracey DiSipio, Beth Newman
Affiliations

Upper-body morbidity following breast cancer treatment is common, may persist longer-term and adversely influences quality of life

Sandra C Hayes et al. Health Qual Life Outcomes. .

Abstract

Background: Impairments in upper-body function (UBF) are common following breast cancer. However, the relationship between arm morbidity and quality of life (QoL) remains unclear. This investigation uses longitudinal data to describe UBF in a population-based sample of women with breast cancer and examines its relationship with QoL.

Methods: Australian women (n=287) with unilateral breast cancer were assessed at three-monthly intervals, from six- to 18-months post-surgery (PS). Strength, endurance and flexibility were used to assess objective UBF, while the Disability of the Arm, Shoulder and Hand questionnaire and the Functional Assessment of Cancer Therapy-Breast questionnaire were used to assess self-reported UBF and QoL, respectively.

Results: Although mean UBF improved over time, up to 41% of women revealed declines in UBF between six- and 18-months PS. Older age, lower socioeconomic position, treatment on the dominant side, mastectomy, more extensive lymph node removal and having lymphoedema each increased odds of declines in UBF by at least two-fold (p<0.05). Lower baseline and declines in perceived UBF between six- and 18-months PS were each associated with poorer QoL at 18-months PS (p<0.05).

Conclusions: Significant upper-body morbidity is experienced by many following breast cancer treatment, persisting longer term, and adversely influencing the QoL of breast cancer survivors.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Proposed relationships between upper-body function, quality of life and survival.
See this image and copyright information in PMC

References

    1. Australian Institute of Health and Welfare and National Breast Cancer Centre. Breast cancer in Australia: an overview. Canberra. 2006.
    1. Satariano W, Ragland D, DeLorenze GN. Limitations in upper-body strength associated with breast cancer: A comparison of black and white women. J Clin Epidemiol. 1996;49:535–544. doi: 10.1016/0895-4356(95)00565-X. - DOI - PubMed
    1. Hladiuk M, Huchcroft S, Temple W, Schnurr BE. Arm function after axillary dissection for breast cancer: A pilot study to provide parameter estimates. J Surg Oncol. 1992;50:47–52. doi: 10.1002/jso.2930500114. - DOI - PubMed
    1. Keramopoulos A, Tsionou C, Minaretzis D, Michalas S. Arm morbidity following treatment of breast cancer with total axillary dissection: A multivariated approach. Oncology. 1993;50:445–449. doi: 10.1159/000227227. - DOI - PubMed
    1. Lilijegren G, Holmberg L. Uppsala Orebro Breast Cancer Study Group. Arm morbidity after section resection and axillary dissection with or without postoperative radiotherapy in breast cancer stage I. Results from a randomised trial. Eur J Cancer. 1997;33:193–199. doi: 10.1016/S0959-8049(96)00375-9. - DOI - PubMed

Publication types

MeSH terms